Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. INFU
stocks logo

INFU

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
36.64M
+8.24%
0.072
+81.25%
35.53M
+2.36%
0.030
-400%
37.98M
+5.5%
0.102
-14.58%
Estimates Revision
The market is revising Downward the revenue expectations for InfuSystem Holdings, Inc. (INFU) for FY2025, with the revenue forecasts being adjusted by -0.23% over the past three months. During the same period, the stock price has changed by -11.81%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.23%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+13.73%
In Past 3 Month
Stock Price
Go Down
down Image
-11.81%
In Past 3 Month
Wall Street analysts forecast INFU stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INFU is 13.67 USD with a low forecast of 12.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast INFU stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INFU is 13.67 USD with a low forecast of 12.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 8.960
sliders
Low
12.00
Averages
13.67
High
15.00
Current: 8.960
sliders
Low
12.00
Averages
13.67
High
15.00
Roth Capital
Buy
maintain
$13 -> $14
2025-11-04
Reason
Roth Capital
Price Target
$13 -> $14
2025-11-04
maintain
Buy
Reason
Roth Capital raised the firm's price target on InfuSystem to $14 from $13 and keeps a Buy rating on the shares. The company's Q3 results were in-line with revenue expectations and above on earnings, with the core Oncology business in Patient Services continuing to perform and management remaining focused on executing opportunities that improve profitability, the analyst tells investors in a research note. The firm said that while it reduced its forward revenue expectations, it increased its adjusted EBITDA and EPS estimates slightly, with the higher estimates and lower share count from buybacks resulting in the new price target.
Lake Street
NULL -> Buy
initiated
$15
2025-09-22
Reason
Lake Street
Price Target
$15
2025-09-22
initiated
NULL -> Buy
Reason
Lake Street assumed coverage of InfuSystem with a Buy rating and a price target of $15, up from $12.50. The "leading provider" of infusion pumps and related services, operating under two complementary platforms of Patient Services and Device Solutions, is "laying the groundwork for durable and profitable growth that investors may not fully appreciate today," the analyst argues.
Roth Capital
Kyle Bauser
Buy
initiated
$12
2025-07-21
Reason
Roth Capital
Kyle Bauser
Price Target
$12
2025-07-21
initiated
Buy
Reason
Roth Capital analyst Kyle Bauser initiated coverage of InfuSystem with a Buy rating and $12 price target. InfuSystem operates two key segments - Patient Services and Device Solutions - and the company's ability to automate billing, patient records, and pump tracking allows it to serve a larger base without linearly scaling headcount, the analyst tells investors. The firm believes the company can drive further margin expansion from more efficient operations and additional scale, the analyst added.
B. Riley
B. Riley
Buy
downgrade
$14 -> $12
2025-05-09
Reason
B. Riley
B. Riley
Price Target
$14 -> $12
2025-05-09
downgrade
Buy
Reason
B. Riley lowered the firm's price target on InfuSystem to $12 from $14 and keeps a Buy rating on the shares following the Q1 report. The company remains focused on improving profitability while pursuing growth opportunities such as advanced wound care and chemo mouthpiece, the analyst tells investors in a research note. Riley expects InfuSystem to continue to repurchase shares throughout the year.
See All Ratings

Valuation Metrics

The current forward P/E ratio for InfuSystem Holdings Inc (INFU.A) is 26.99, compared to its 5-year average forward P/E of 78.58. For a more detailed relative valuation and DCF analysis to assess InfuSystem Holdings Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
78.58
Current PE
26.99
Overvalued PE
148.21
Undervalued PE
8.96

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
9.70
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
12.65
Undervalued EV/EBITDA
6.75

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.79
Current PS
0.00
Overvalued PS
2.66
Undervalued PS
0.93
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 1158.53% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

INFU News & Events

Events Timeline

(ET)
2025-11-04
06:44:12
InfuSystem anticipates 6%-8% net revenue growth in 2025, reaching $134.86M in 2024.
select
2025-11-04
06:43:07
InfuSystem announces Q3 earnings per share of 11 cents, up from 8 cents last year.
select
2025-08-05 (ET)
2025-08-05
06:58:09
InfuSystem lowers FY25 revenue growth view to 6%-8% from 8%-10%
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
1.0
11-11Newsfilter
InfuSystem to Attend the 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025

  • Company Participation in Conference: InfuSystem Holdings, Inc. will participate in the 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025, in New York City, with management hosting one-on-one meetings for investors.

  • Business Overview: InfuSystem is a national healthcare service provider specializing in outpatient care for durable medical equipment, operating through two platforms: Patient Services and Device Solutions, with a focus on oncology, pain management, and wound therapy.

  • Forward-Looking Statements: The company includes forward-looking statements regarding its business plans, growth initiatives, and potential revenue, which are subject to various risks and uncertainties that could impact actual results.

  • Contact Information: Investors interested in meetings can contact Craig-Hallum representatives or Lytham Partners for further arrangements, with additional company information available on their website.

[object Object]
Preview
7.0
11-04SeekingAlpha
InfuSystem Confirms 6%–8% Revenue Growth and Over 20% EBITDA Margin Forecast Amid Progress in Profitability Strategy

  • Management Performance: InfuSystem Holdings reported strong Q3 2025 results with record revenue growth, particularly in Oncology and Wound Care, driven by strategic acquisitions and operational improvements, including AI and automation enhancements.

  • Financial Highlights: The company achieved a gross profit of $20.8 million and an adjusted EBITDA margin of 22.8%, while also reducing net debt by $5.7 million and returning $2.2 million in capital to shareholders.

  • Outlook and Guidance: InfuSystem reaffirmed its full-year guidance, targeting 6% to 8% revenue growth and an adjusted EBITDA margin of 20% or greater, emphasizing a shift towards profitability and operational efficiency.

  • Risks and Concerns: Management acknowledged a potential $6 million to $7 million annual revenue reduction from a contract amendment in biomedical services, but expects cost reductions to offset this decline, while analysts raised concerns about growth in Device Solutions.

[object Object]
Preview
9.5
11-04NASDAQ.COM
InfuSystem Holdings, Inc Reports Q3 Profit Increase, Surpassing Expectations

  • Earnings Performance: InfuSystem Holdings, Inc reported a third-quarter earnings increase to $2.25 million, or $0.11 per share, surpassing last year's $1.80 million, or $0.08 per share.

  • Analyst Expectations: The company's earnings exceeded analysts' expectations, who had predicted earnings of $0.05 per share, excluding special items.

  • Revenue Growth: Revenue for the quarter rose by 3.3% to $36.48 million, compared to $35.32 million in the same period last year.

  • Earnings Summary: Key financial figures include earnings of $2.25 million, EPS of $0.11, and revenue of $36.48 million, all showing positive growth from the previous year.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is InfuSystem Holdings Inc (INFU) stock price today?

The current price of INFU is 8.96 USD — it has decreased -4.07 % in the last trading day.

arrow icon

What is InfuSystem Holdings Inc (INFU)'s business?

InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.

arrow icon

What is the price predicton of INFU Stock?

Wall Street analysts forecast INFU stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INFU is 13.67 USD with a low forecast of 12.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is InfuSystem Holdings Inc (INFU)'s revenue for the last quarter?

InfuSystem Holdings Inc revenue for the last quarter amounts to 36.49M USD, increased 3.31 % YoY.

arrow icon

What is InfuSystem Holdings Inc (INFU)'s earnings per share (EPS) for the last quarter?

InfuSystem Holdings Inc. EPS for the last quarter amounts to 0.11 USD, increased 37.50 % YoY.

arrow icon

What changes have occurred in the market's expectations for InfuSystem Holdings Inc (INFU)'s fundamentals?

The market is revising Downward the revenue expectations for InfuSystem Holdings, Inc. (INFU) for FY2025, with the revenue forecasts being adjusted by -0.23% over the past three months. During the same period, the stock price has changed by -11.81%.
arrow icon

How many employees does InfuSystem Holdings Inc (INFU). have?

InfuSystem Holdings Inc (INFU) has 502 emplpoyees as of December 05 2025.

arrow icon

What is InfuSystem Holdings Inc (INFU) market cap?

Today INFU has the market capitalization of 182.21M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free